Search research articles
Contact Us
Filters
Showing results (41-50 of 109) with videos related to
Page
of 11
Sort By:
Clinical Lymphoma, Myeloma & Leukemia
|
June 10, 2025
Blood-Based Measurable Residual Disease by Clonotypic Mass Spectrometry is Prognostic in Patients With Multiple Myeloma Undergoing Autologous Hematopoietic Cell Transplant
Michael J Slade, Julie Fortier, Abir Khaled, et al.
Cancers
|
August 10, 2024
An Injury-like Signature of the Extracellular Glioma Metabolome
Yooree Ha, Karishma Rajani, Cecile Riviere-Cazaux, et al.
Neuro-Oncology
|
October 28, 2008
Induction of MGMT expression is associated with temozolomide resistance in glioblastoma xenografts
Gaspar J Kitange, Brett L Carlson, Mark A Schroeder, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 20, 2014
Discordant in vitro and in vivo chemopotentiating effects of the PARP inhibitor veliparib in temozolomide-sensitive versus -resistant glioblastoma multiforme xenografts
Shiv K Gupta, Ann C Mladek, Brett L Carlson, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
January 15, 2017
T Cell-Replete Peripheral Blood Haploidentical Hematopoietic Cell Transplantation with Post-Transplantation Cyclophosphamide Results in Outcomes Similar to Transplantation from Traditionally Matched Donors in Active Disease Acute Myeloid Leukemia
Joan How, Michael Slade, Khoan Vu, et al.
Plos One
|
January 28, 2014
The role of factor inhibiting HIF (FIH-1) in inhibiting HIF-1 transcriptional activity in glioblastoma multiforme
Enfeng Wang, Chunyang Zhang, Navatha Polavaram, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 7, 2019
A Phase I/II Trial of Carfilzomib, Pegylated Liposomal Doxorubicin, and Dexamethasone for the Treatment of Relapsed/Refractory Multiple Myeloma
Mark A Schroeder, Mark A Fiala, Eric Huselton, et al.
Transplantation and Cellular Therapy
|
February 22, 2023
A Multicenter Phase 2 Clinical Trial of 10-Day Decitabine, Dose-Escalated Donor Lymphocyte Infusion, and Ruxolitinib for Relapsed Acute Myeloid Leukemia and Myelodysplastic Syndromes after Allogeneic Hematopoietic Cell Transplantation
Armin Rashidi, Eric J Huselton, Heather E Stefanski, et al.
Molecular Cancer Therapeutics
|
March 17, 2007
Identification of molecular characteristics correlated with glioblastoma sensitivity to EGFR kinase inhibition through use of an intracranial xenograft test panel
Jann N Sarkaria, Lin Yang, Patrick T Grogan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 13, 2006
Use of an orthotopic xenograft model for assessing the effect of epidermal growth factor receptor amplification on glioblastoma radiation response
Jann N Sarkaria, Brett L Carlson, Mark A Schroeder, et al.
Page
of 11
Search research articles
Search
Showing results (41-50 of 109) with videos related to
Sort By:
Page
of 11
Clinical Lymphoma, Myeloma & Leukemia
|
June 10, 2025
Blood-Based Measurable Residual Disease by Clonotypic Mass Spectrometry is Prognostic in Patients With Multiple Myeloma Undergoing Autologous Hematopoietic Cell Transplant
Michael J Slade, Julie Fortier, Abir Khaled, et al.
Cancers
|
August 10, 2024
An Injury-like Signature of the Extracellular Glioma Metabolome
Yooree Ha, Karishma Rajani, Cecile Riviere-Cazaux, et al.
Neuro-Oncology
|
October 28, 2008
Induction of MGMT expression is associated with temozolomide resistance in glioblastoma xenografts
Gaspar J Kitange, Brett L Carlson, Mark A Schroeder, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 20, 2014
Discordant in vitro and in vivo chemopotentiating effects of the PARP inhibitor veliparib in temozolomide-sensitive versus -resistant glioblastoma multiforme xenografts
Shiv K Gupta, Ann C Mladek, Brett L Carlson, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
January 15, 2017
T Cell-Replete Peripheral Blood Haploidentical Hematopoietic Cell Transplantation with Post-Transplantation Cyclophosphamide Results in Outcomes Similar to Transplantation from Traditionally Matched Donors in Active Disease Acute Myeloid Leukemia
Joan How, Michael Slade, Khoan Vu, et al.
Plos One
|
January 28, 2014
The role of factor inhibiting HIF (FIH-1) in inhibiting HIF-1 transcriptional activity in glioblastoma multiforme
Enfeng Wang, Chunyang Zhang, Navatha Polavaram, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 7, 2019
A Phase I/II Trial of Carfilzomib, Pegylated Liposomal Doxorubicin, and Dexamethasone for the Treatment of Relapsed/Refractory Multiple Myeloma
Mark A Schroeder, Mark A Fiala, Eric Huselton, et al.
Transplantation and Cellular Therapy
|
February 22, 2023
A Multicenter Phase 2 Clinical Trial of 10-Day Decitabine, Dose-Escalated Donor Lymphocyte Infusion, and Ruxolitinib for Relapsed Acute Myeloid Leukemia and Myelodysplastic Syndromes after Allogeneic Hematopoietic Cell Transplantation
Armin Rashidi, Eric J Huselton, Heather E Stefanski, et al.
Molecular Cancer Therapeutics
|
March 17, 2007
Identification of molecular characteristics correlated with glioblastoma sensitivity to EGFR kinase inhibition through use of an intracranial xenograft test panel
Jann N Sarkaria, Lin Yang, Patrick T Grogan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 13, 2006
Use of an orthotopic xenograft model for assessing the effect of epidermal growth factor receptor amplification on glioblastoma radiation response
Jann N Sarkaria, Brett L Carlson, Mark A Schroeder, et al.
Page
of 11